Epoch Biodesign, a London-based company developing enzymatic recycling technology, has closed a $12 million strategic funding round with participation from lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif and others. The new investment brings the company’s total funding to over $50 million. Epoch is focused on advancing circularity in materials by enabling the recycling of nylon 6,6 wi...